US$ 24.72
benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP Phase II Drug Metabolism |
Description
Combine peptides with lifestyle interventions, such as a healthy diet, consistent exercise, quality sleep, reducing toxin exposure, and maintaining optimal stress levels, to optimize potency and long-term fertility
![benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP Phase II Drug Metabolism |](https://cdnintech.com/media/chapter/29241/1512345123/media/image3.jpg)
Bramwell Cook defined a syndrome in late 1944 related to vitamin B12 deficiency, entailing hyperpigmentation, glossitis, and macrocytic megaloblastic anemia as its primary features
![benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP Phase II Drug Metabolism |](https://ars.els-cdn.com/content/image/1-s2.0-S0048969724060339-ga1.jpg)
[DOI] [PubMed] [Google Scholar] 153
![benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP Phase II Drug Metabolism |](https://www.researchgate.net/profile/Meng-Ye-11/publication/221926860/figure/fig1/AS:305064276185088@1449744399755/The-metabolic-conversion-of-benzoapyrene-into-a-mutagen-a-Benzoapyrene-goes.png)
2 (February 2023): 102382
![benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP Phase II Drug Metabolism |](https://www.researchgate.net/publication/328070467/figure/fig1/AS:677997531123723@1538658616288/Benzoapyrene-BaP-bioactivation-Major-mechanism-of-DNA-binding-by-BaP-a.png)